Nuclear receptors and epigenetic signaling: Novel regulators of glycogen metabolism in skeletal muscle

IUBMB Life

Volumn 65, Issue 8, 2013, Pages 657-664

  Wang, Shu Ching Mary ^a   Muscat, George E O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

glycogen; nuclear receptors

Indexed keywords

CATECHOLAMINE; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE METHYLTRANSFERASE; HORMONE RECEPTOR; HORMONE RECEPTOR 4A; NUCLEAR RECEPTOR NR4A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 4; UNCLASSIFIED DRUG;

BETA ADRENERGIC STIMULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENERGY METABOLISM; EPIGENETICS; EXERCISE; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; GLYCOGEN METABOLISM; GLYCOGEN STORAGE DISEASE; HUMAN; OXIDATIVE PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

EID: 84886368558     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1181     Document Type: Review

References (74)

1. Jensen, T. E., and, Richter, E. A., (2012) Regulation of glucose and glycogen metabolism during and after exercise. J. Physiol. 590, 1069-1076.
2. Jensen, J., Rustad, P. I., Kolnes, A. J., and, Lai, Y. C., (2011) The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise. Front. Physiol. 2, 112.
3. Holloszy, J. O., and, Kohrt, W. M., (1996) Regulation of carbohydrate and fat metabolism during and after exercise. Annu. Rev. Nutr. 16, 121-138. (Pubitemid 26286849)
4. Holloszy, J. O., Kohrt, W. M., and, Hansen, P. A., (1998) The regulation of carbohydrate and fat metabolism during and after exercise. Front. Biosci. 3, D1011-D1027.
5. Kjaer, M., Secher, N. H., and, Galbo, H., (1987) Physical stress and catecholamine release. Baillieres Clin. Endocrinol. Metab. 1, 279-298.
6. Watt, M. J., and, Hargreaves, M., (2002) Effect of epinephrine on glucose disposal during exercise in humans: role of muscle glycogen. Am. J. Physiol. Endocrinol. Metab. 283, E578-E583. (Pubitemid 35230496)
7. Kiens, B., (2006) Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Rev. 86, 205-243.
8. Watt, M. J., Heigenhauser, G. J., and, Spriet, L. L., (2003) Effects of dynamic exercise intensity on the activation of hormone-sensitive lipase in human skeletal muscle. J. Physiol. 547, 301-308. (Pubitemid 36285183)
9. Akimoto, T., Ribar, T. J., Williams, R. S., and, Yan, Z., (2004) Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice. Am. J. Physiol. Cell. Physiol. 287, C1311-C1319. (Pubitemid 39382890)
10. Thonberg, H., Fredriksson, J. M., Nedergaard, J., and, Cannon, B., (2002) A novel pathway for adrenergic stimulation of cAMP-response-element-binding protein (CREB) phosphorylation: mediation via alpha1-adrenoceptors and protein kinase C activation. Biochem. J. 364, 73-79. (Pubitemid 34538948)
11. Li, B., Kaetzel, M. A., and, Dedman, J. R., (2006) Signaling pathways regulating murine cardiac CREB phosphorylation. Biochem. Biophys. Res. Commun. 350, 179-184. (Pubitemid 44466589)
12. Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., et al. (2007) Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J. Biol. Chem. 282, 30014-30021. (Pubitemid 350035265)
13. Lynch, G. S., and, Ryall, J. G., (2008) Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol. Rev. 88, 729-767. (Pubitemid 351520091)
14. Chao, L. C., Zhang, Z., Pei, L., Saito, T., Tontonoz, P., et al. (2007) Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 21, 2152-2163. (Pubitemid 47347379)
15. Wang, S. C., Dowhan, D. H., Eriksson, N. A., and, Muscat, G. E., (2012) CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. Biochem. J. 444, 323-331.
16. Chao, L. C., Wroblewski, K., Zhang, Z., Pei, L., Vergnes, L., et al. (2009) Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 58, 2788-2796.
17. Mormeneo, E., Jimenez-Mallebrera, C., Palomer, X., De Nigris, V., Vazquez-Carrera, M., et al. (2012) PGC-1alpha induces mitochondrial and myokine transcriptional programs and lipid droplet and glycogen accumulation in cultured human skeletal muscle cells. PLoS One 7, e29985.
18. Philp, A., Hargreaves, M., and, Baar, K., (2012) More than a store: regulatory roles for glycogen in skeletal muscle adaptation to exercise. Am. J. Physiol. Endocrinol. Metab. 302, E1343-E1351.
19. Hargreaves, M., (2004) Muscle glycogen and metabolic regulation. Proc. Nutr. Soc. 63, 217-220. (Pubitemid 38787468)
20. Summermatter, S., and, Handschin, C., (2012) PGC-1alpha and exercise in the control of body weight. Int. J. Obes. (Lond). 36, 1428-1435.
21. Miura, S., Kawanaka, K., Kai, Y., Tamura, M., Goto, M., et al. (2007) An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Endocrinology 148, 3441-3448. (Pubitemid 46997005)
22. Akimoto, T., Sorg, B. S., and, Yan, Z., (2004) Real-time imaging of peroxisome proliferator-activated receptor-gamma coactivator-1alpha promoter activity in skeletal muscles of living mice. Am. J. Physiol. Cell Physiol. 287, C790-C796. (Pubitemid 39095866)
23. Wende, A. R., Schaeffer, P. J., Parker, G. J., Zechner, C., Han, D. H., et al. (2007) A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J. Biol. Chem. 282, 36642-36651.
24. Abruzzo, P. M., Esposito, F., Marchionni, C., di Tullio, S., Belia, S., et al. (2013) Moderate exercise training induces ROS-related adaptations to skeletal muscles. Int. J. Sports Med., Epub.
25. Ristow, M., Zarse, K., Oberbach, A., Kloting, N., Birringer, M., et al. (2009) Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA. 106, 8665-8670.
26. Sindler, A. L., Reyes, R., Chen, B., Ghosh, P., Gurovich, A. N., et al. (2013) Age and exercise training alter signaling through reactive oxygen species in the endothelium of skeletal muscle arterioles. J. Appl. Physiol. 114, 681-693.
27. McGee, S. L., and, Hargreaves, M., (2011) Histone modifications and exercise adaptations. J. Appl. Physiol. 110, 258-263.
28. Pearen, M. A., and, Muscat, G. E., (2010) Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 24, 1891-1903.
29. Smith, A. G., and, Muscat, G. E., (2005) Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int. J. Biochem. Cell Biol. 37, 2047-2063. (Pubitemid 41206820)
30. Smith, A. G., and, Muscat, G. E., (2006) Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. Am. J. Physiol. Cell Physiol. 291, C203-C217. (Pubitemid 44148142)
31. Pearen, M. A., Myers, S. A., Raichur, S., Ryall, J. G., Lynch, G. S., et al. (2008) The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149, 2853-2865. (Pubitemid 351724495)
32. Pearen, M. A., Ryall, J. G., Lynch, G. S., and, Muscat, G. E., (2009) Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm. BMC Genomics 10, 448.
33. Pearen, M. A., Ryall, J. G., Maxwell, M. A., Ohkura, N., Lynch, G. S., et al. (2006) The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle. Endocrinology 147, 5217-5227. (Pubitemid 44790577)
34. Maxwell, M. A., Cleasby, M. E., Harding, A., Stark, A., Cooney, G. J., et al. (2005) Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J. Biol. Chem. 280, 12573-12584.
35. Myers, S. A., Eriksson, N., Burow, R., Wang, S. C., and, Muscat, G. E., (2009) Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol. Cell. Endocrinol. 309, 101-108.
36. Mahoney, D. J., Parise, G., Melov, S., Safdar, A., and, Tarnopolsky, M. A., (2005) Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J. 19, 1498-1500. (Pubitemid 41279010)
37. Christensen, N. J., and, Galbo, H., (1983) Sympathetic nervous activity during exercise. Annu. Rev. Physiol. 45, 139-153.
38. Pearen, M. A., Eriksson, N. A., Fitzsimmons, R. L., Goode, J. M., Martel, N., et al. (2012) The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue. Mol. Endocrinol. 26, 372-384.
39. Tadaishi, M., Miura, S., Kai, Y., Kawasaki, E., Koshinaka, K., et al. (2011) Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1alpha mRNA: a role of beta(2)-adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 300, E341-E349.
40. Millay, D. P., and, Olson, E. N., (2013) Making muscle or mitochondria by selective splicing of PGC-1alpha. Cell. Metab. 17, 3-4.
41. Jiang, S., Wells, C. D., and, Roach, P. J., (2011) Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem. Biophys. Res. Commun. 413, 420-425.
42. Parker, G. E., Pederson, B. A., Obayashi, M., Schroeder, J. M., Harris, R. A., et al. (2006) Gene expression profiling of mice with genetically modified muscle glycogen content. Biochem. J. 395, 137-145.
43. Lee, Y. H., and, Stallcup, M. R., (2009) Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol. Endocrinol. 23, 425-433.
44. Lonard, D. M., and, O'Malley, B. W., (2012) Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat. Rev. Endocrinol. 8, 598-604.
45. Yokoyama, A., Fujiki, R., Ohtake, F., and, Kato, S., (2011) Regulated histone methyltransferase and demethylase complexes in the control of genes by nuclear receptors. Cold Spring Harb. Symp. Quant. Biol. 76, 165-173.
46. Bedford, M. T., and, Clarke, S. G., (2009) Protein arginine methylation in mammals: who, what, and why. Mol. Cell. 33, 1-13.
47. Iwasaki, H., and, Yada, T., (2007) Protein arginine methylation regulates insulin signaling in L6 skeletal muscle cells. Biochem. Biophys. Res. Commun. 364, 1015-1021. (Pubitemid 350087901)
48. Krones-Herzig, A., Mesaros, A., Metzger, D., Ziegler, A., Lemke, U., et al. (2006) Signal-dependent control of gluconeogenic key enzyme genes through coactivator-associated arginine methyltransferase 1. J. Biol. Chem. 281, 3025-3029. (Pubitemid 43845911)
49. Chen, S. L., Loffler, K. A., Chen, D., Stallcup, M. R., and, Muscat, G. E., (2002) The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J. Biol. Chem. 277, 4324-4333. (Pubitemid 34968698)
50. Bassel-Duby, R., and, Olson, E. N., (2006) Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75, 19-37. (Pubitemid 44118024)
51. Czubryt, M. P., McAnally, J., Fishman, G. I., and, Olson, E. N., (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA 100, 1711-1716. (Pubitemid 36254513)
52. McGee, S. L., and, Hargreaves, M., (2004) Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 53, 1208-1214. (Pubitemid 38569005)
53. Meissner, J. D., Umeda, P. K., Chang, K. C., Gros, G., and, Scheibe, R. J., (2007) Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. J. Cell. Physiol. 211, 138-148. (Pubitemid 46363903)
54. Potthoff, M. J., Wu, H., Arnold, M. A., Shelton, J. M., Backs, J., et al. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459-2467. (Pubitemid 47494347)
55. Youn, H. D., Chatila, T. A., and, Liu, J. O., (2000) Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19, 4323-4331. (Pubitemid 30623743)
56. Jablonka, E., and, Lamm, E., (2012) Commentary: the epigenotype - a dynamic network view of development. Int. J. Epidemiol. 41, 16-20.
57. Akhtar, A., and, Cavalli, G., (2005) The epigenome network of excellence. PLoS Biol. 3, e177.
58. McCarthy, A., (2011) Epizyme: plying the epigenome's enzymes. Chem. Biol. 18, 403-404.
59. Wigle, T. J., (2011) Promoting illiteracy in epigenetics: an emerging therapeutic strategy. Curr. Chem. Genomics. 5, 48-50.
60. Copeland, R. A., Solomon, M. E., and, Richon, V. M., (2009) Protein methyltransferases as a target class for drug discovery. Nat. Rev. Drug Discov. 8, 724-732.
61. Richon, V. M., Johnston, D., Sneeringer, C. J., Jin, L., Majer, C. R., et al. (2011) Chemogenetic analysis of human protein methyltransferases. Chem. Biol. Drug Des. 78, 199-210.
62. El-Osta, A., (2012) Glycemic memory. Curr. Opin. Lipidol. 23, 24-29.
63. Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., et al. (2011) Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 21, 1601-1615.
64. Syreeni, A., El-Osta, A., Forsblom, C., Sandholm, N., Parkkonen, M., et al. (2011) Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes. Diabetes 60, 3073-3080.
65. Naini, A., Toscano, A., Musumeci, O., Vissing, J., Akman, H. O., et al. (2009) Muscle phosphoglycerate mutase deficiency revisited. Arch. Neurol. 66, 394-398.
66. Hicks, J., Wartchow, E., and, Mierau, G., (2011) Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct. Pathol. 35, 183-196.
67. Ozen, H., (2007) Glycogen storage diseases: new perspectives. World J. Gastroenterol. 13, 2541-2553. (Pubitemid 46938823)
68. Shin, Y. S., (2006) Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin. Pediatr. Neurol. 13, 115-120. (Pubitemid 44486826)
69. Wolfsdorf, J. I., and, Weinstein, D. A., (2003) Glycogen storage diseases. Rev. Endocr. Metab. Disord. 4, 95-102. (Pubitemid 36182154)
70. Chou, J. Y., Matern, D., Mansfield, B. C., and, Chen, Y. T., (2002) Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2, 121-143. (Pubitemid 34649836)
71. Janecke, A. R., Mayatepek, E., and, Utermann, G., (2001) Molecular genetics of type 1 glycogen storage disease. Mol. Genet. Metab. 73, 117-125. (Pubitemid 32550149)
72. Andersen, D. H., (1956) Familial cirrhosis of the liver with storage of abnormal glycogen. Lab. Invest. 5, 11-20.
73. Kishnani, P. S., and, Howell, R. R., (2004) Pompe disease in infants and children. J. Pediatr. 144, S35-S43. (Pubitemid 38591273)
74. Poenaru, L., (2000) Approach to gene therapy of glycogenosis type II (Pompe disease). Mol. Genet. Metab. 70, 163-169. (Pubitemid 30640769)